Cargando…

Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilot

BACKGROUND: Overcalling of abnormalities has been a concern for using cytology triage after positive high‐risk human papillomavirus (HPV) tests in cervical screening. METHODS: The authors studied the detection of cytological and histological abnormalities at age 24 to 64 years, using data from the E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rebolj, Matejka, Mathews, Christopher S., Denton, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542289/ https://www.ncbi.nlm.nih.gov/pubmed/35377967 http://dx.doi.org/10.1002/cncy.22572

Ejemplares similares

The impact of catch-up bivalent human papillomavirus vaccination on cervical screening outcomes: an observational study from the English HPV primary screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2022)

16/18 genotyping in triage of persistent human papillomavirus infections with negative cytology in the English cervical screening pilot
por: Rebolj, Matejka, et al.
Publicado: (2019)

Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data
por: Rebolj, Matejka, et al.
Publicado: (2022)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Primary cervical screening with high risk human papillomavirus testing: observational study
por: Rebolj, Matejka, et al.
Publicado: (2019)

Supporting the implementation of new healthcare technologies by investigating generalisability of pilot studies using area-level statistics
por: Doorbar, James Alexander, et al.
Publicado: (2022)

Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review
por: Rebolj, Matejka, et al.
Publicado: (2011)

Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening
por: Rebolj, M, et al.
Publicado: (2010)

Human Papillomavirus Testing in the Last Cervical Screening Round at Age 60–64 Years
por: Schroll, Jeppe Bennekou, et al.
Publicado: (2021)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Shifting from cytology to HPV testing for cervical cancer screening in Canada
por: Delpero, Emily, et al.
Publicado: (2022)

Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting
por: Kotaniemi-Talonen, L, et al.
Publicado: (2005)

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
por: Dillner, Joakim, et al.
Publicado: (2008)

Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing
por: Vassilakos, P, et al.
Publicado: (2002)

COVID-19 disruption to cervical cancer screening in England
por: Castanon, Alejandra, et al.
Publicado: (2022)

Cost effectiveness analysis of HPV primary screening and dual stain cytology triage compared with cervical cytology
por: Termrungruanglert, Wichai, et al.
Publicado: (2018)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

Performance of cervical cytology and HPV testing for primary cervical cancer screening in Latin America: an analysis within the ESTAMPA study
por: Ramírez, Arianis Tatiana, et al.
Publicado: (2023)

Comparison of primary cytology, primary HPV testing and co-testing as cervical cancer screening for Chinese women: a population-based screening cohort
por: Li, Zhi-Fang, et al.
Publicado: (2022)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
por: Bonde, Jesper, et al.
Publicado: (2014)

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
por: Rozemeijer, Kirsten, et al.
Publicado: (2017)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies
por: Pista, Angela, et al.
Publicado: (2019)

Concurrent participation in breast, cervical, and colorectal cancer screening programmes in Denmark: A nationwide registry-based study
por: Njor, Sisse Helle, et al.
Publicado: (2023)

Adherence to follow‐up after the exit cervical cancer screening test at age 60–64: A nationwide register‐based study
por: Jørgensen, Susanne F., et al.
Publicado: (2021)

Cost-Effectiveness of Primary HPV Screening Strategies and Triage With Cytology or Dual Stain for Cervical Cancer
por: Tantitamit, Tanitra, et al.
Publicado: (2020)

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study
por: Ejegod, Ditte Møller, et al.
Publicado: (2015)

Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial – the HPV FOCAL Study
por: Ogilvie, G S, et al.
Publicado: (2012)

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
por: Flores, Yvonne N., et al.
Publicado: (2010)

Validity and Reliability of Using a Self-Lavaging Device for Cytology and HPV Testing for Cervical Cancer Screening: Findings from a Pilot Study
por: Jones, Heidi E., et al.
Publicado: (2013)

The impact of knowledge of HPV positivity on cytology triage in primary high-risk HPV screening
por: Aitken, Clare A, et al.
Publicado: (2019)

Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
por: Canfell, Karen, et al.
Publicado: (2017)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

A Model Approach for Assessing the Benefits of HPV Testing against Cytology in Screening for Cervical Cancer Precursors in Thailand
por: Tantitamit, Tanitra, et al.
Publicado: (2017)

Error Rates in Cervical Cytological Screening Tests
por: May, D.
Publicado: (1974)

Detection and Outcome of Endocervical Atypia in Cytology in Primary HPV Screening Programme
por: Pulkkinen, Johanna, et al.
Publicado: (2021)

Introducing human papillomavirus (HPV) primary testing in the age of HPV vaccination: projected impact on colposcopy services in Wales
por: Pesola, F, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uuso2tjhbcou4akrjakn3ju6qd